Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

GFI1 (growth factor independent 1 transcription repressor)

Written2011-03Tarik Möröy, Cyrus Khandanpour
Institut de recherches cliniques de Montreal, 110 Avenue des Pins Ouest, H2W1R7, Montreal, Canada

(Note : for Links provided by Atlas : click)


Alias (NCBI)FLJ94509
HGNC (Hugo) GFI1
HGNC Alias symbGFI1A
HGNC Previous nameZNF163
HGNC Previous namegrowth factor independent 1
LocusID (NCBI) 2672
Atlas_Id 40706
Location 1p22.1  [Link to chromosome band 1p22]
Location_base_pair Starts at 92473043 and ends at 92486925 bp from pter ( according to GRCh38/hg38-Dec_2013)  [Mapping GFI1.png]
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)


Description The GFI1 locus consists of 7 exons of which 6 are coding. Depending on different reported variants, the position of the first, non-coding, exon 1, can vary.
Pseudogene None known.


  Figure 1. GFI1 protein (from Möröy and Khandanpour).
Description Both human and murine Gfi1 proteins consist of 422 amino acids and have a mass of 45297 Da. The isoelectric point is 9.24. Gfi1 contains six c-terminal C2H2-type zinc-finger domains and an N-terminal SNAG domain critical for its repressor activity (figure 1). Zinc fingers 3 to 5 of Gfi1 recognize and bind to the DNA sequence taAATCac(t/a)gca. Zinc fingers 1, 2 and 6 are required for the interaction with other proteins (Bell et al., 1995; Duan and Horwitz, 2003; Gilks et al., 1993; Grimes et al., 1996; Hock et al., 2003; Person et al., 2003; Zweidler-Mckay et al., 1996).
Expression Mice carrying a GFP reporter gene within the Gfi1 locus allowed studying in detail Gfi1 expression during differentiation of the different compartments in vivo (Yücel et al., 2004; Zeng et al., 2004). Gfi1 plays a major role in the stem cell fraction, B-, T- and myeloid compartment, whereas it is relatively low expressed in the megakaryocytic-erythroid compartment. In this cell population, the Gfi1 paralogue Gfi1b exerts important functions. To facilitate the overview we will describe the expression for each compartment separately.

Hematopoietic stem cells and early progenitors
All blood cells originate from hematopoietic stem cells (HSCs). These cells have a high self-renewal capacity and upon cell division, either one HSC gives rise to two HSC daughter cells or to one HSC and one so-called Multipotential Progenitors (MPPs). These MPPs differentiate via MPP1, MPP2 and MPP3 to the different progenitors of the myeloid, erythroid, megakaryocytic and lymphoid compartments. Gfi1 is present in HSCs, albeit at low levels compared to HSC progeny such as MPP1 and MPP2 (measured in Gfi1: GFP knockin reporter mice (Khandanpour et al., 2010b).

Myeloid compartment
MPPs can differentiate to so called common myeloid progenitor cells (CMPs), which in turn give rise to either megakaryocyte-erythrocyte progenitors (MEPs) or granulocytic monocytic progenitors (GMPs). GMPs develop either into cells of the monocytic or granulocytic lineage. Gfi1 expression increases upon differentiation of CMPs towards GMPs and finally to granulocytes (Zeng et al., 2004). Yet, commitment of CMP towards MEPs and the mature erythroid and megakaryocytic compartment is accompanied by increasingly lower level of Gfi1. In this fraction, the paralogue Gfi1b plays a more important role (Vassen et al., 2007).

The common lymphoid progenitors (CLPs) are thought to be one of the earliest B-cell precursors. During early B-cells differentiation, Gfi1 is expressed highest in CLPs and upon differentiation of CLPs into the different more mature B-cell progenitor fractions, Gfi1 expression is gradually down regulated and it is hardly detectable in immature IgM positive B-cells (Yücel et al., 2004; Zeng et al., 2004). However, upon antigen stimulation, mature B-cells induce expression of Gfi1 (Igwe et al., 2008; Rathinam and Klein, 2007; Rathinam et al., 2008).

T cells originate in the thymus, where they develop from early lymphoid progenitors (ELPs) that migrate from the bone marrow to the thymus where they become early thymic progenitors (ETPs). ETPs differentiate via various CD4, CD8 double negative (so called "DN") stages to double positive (DP, CD4+, CD8+) cells to single positive (CD4+, CD8+) cells (Awong et al., 2010; Dervovic and Zúñiga-Pflücker, 2010; Holmes and Zúñiga-Pflücker, 2009; Michie et al., 2007; Wang et al., 2010; Zúñiga-Pflücker, 2009; Zúñiga-Pflücker and van den Brink, 2007). During these developmental stages, Gfi1 expression is differentially regulated. A peak of expression is observed in DN3 cells at the time of beta selection (Yücel et al., 2004), suggesting that Gfi1 plays a role in this first receptor mediated selection process during pre T-cell development. In peripheral T-cells, Gfi1 expression is lower than in thymocytes, but is still detectable and can be induced upon stimulation of the T cell receptor by antigen.

Outside the hematopoietic system
Gfi1 is also expressed in sensory epithelia such as inner ear hair cells, in specific cells of the retina, the intestinal and lung epithelia and in the central nervous system in Purkinje cells (see below).

Localisation Gfi1 is localized in the cell nucleus and immune fluorescence staining demonstrates a typical dot-like pattern of distribution. Occasionally Gfi1 can be found at the nuclear membrane. These patterns vary whether endogenous or over-expressed Gfi1 is detected.
Function The molecular function of Gfi1 is that of a DNA-binding transcriptional repressor. A target gene sequence has been defined (Gilks et al., 1993; Zweidler-Mckay et al., 1996) and a number of target genes have been validated by different groups (see below under "Biolocigal role"). By binding to target gene promoters Gfi1 can recruit a number of cofactors that modify histone H3 N-terminal ends to the effect of transcriptional repression. The best characterized co-factors are histone deacetylases (HDAC1; HDAC2; HDAC3), histone methyl transferases (G9a) and histone de-methylases (LSD1 and the LSD1-CoRest complex). It has been proposed that Gfi1 can initiate transient transcriptional silencing via histone deacetylation and de-methylation in particular at H3K4, but can also induce more permanent repression by recruiting G9a, which mediates the di-methylation of H3K9. It is possible that other methyl transferases are recruited such as SUV39H1 that induce H3K9 trimethylation and heterochromatin formation, which leads to permanent gene silencing (Saleque et al., 2007; Duan et al., 2005).

- Biological role

The generation of constitutive and conditional Gfi1 deficient mouse strains has helped to elucidate the biological role that Gfi1 plays in the hematopoietic system. Similar to the approach in the passage describe above, we will describe the role of Gfi1 in the different hematopoietic compartments.

Hematopoietic stem cells
Gfi1-/- HSCs are characterized by their severely disturbed self-renewal and their inability to reconstitute hematopoietic lineages in a transplanted host (Hock et al., 2004; Möröy, 2005; Zeng et al., 2004). Two physiological functions of Gfi1 may explain these observations. Gfi1 restricts HSC proliferation by controlling the expression of the negative cell cycle regulator p21waf/cip1. The mechanisms underlying this regulation are unclear, but two independent studies confirmed that Gfi1 deficient HSCs undergo more cell cycling and express reduced levels of p21waf/cip1 compared to HSCs from wt mice. It is postulated that this increased proliferation impairs the function of Gfi1-/- HSCs (Hock et al., 2004; Zeng et al., 2004). In addition, Gfi1 was found to be critical to protect HSCs against stress-induced apoptosis (e.g. induced by transplantation). In support of this, expression of a Bcl-2 transgene that counteracts apoptotic signals rescued partially the defects of Gfi1 deficient HSCs (Khandanpour et al., 2010a).

Myeloid cells
Gfi1 plays an important role in myeloid differentiation. Gfi1-/- mice have increased numbers of myeloid precursors (CMPs, GMPs) (Horman et al., 2009; Zeng et al., 2004) with an increased expression of Hoxa9, Pbx or Meis1. Gfi1 seems to be required to down regulate Hoxa9, Pbx1, Meis 1 expression to ensure a proper differentiation from CMPs to GMPs and finally to neutrophil granulocytes. Moreover, Gfi1 represses the expression of PU.1, CSF1R, miR-21, miR-196b, Egr-Nab and Id2, mostly by directly binding to their promoters. All of these genes are implicated in myeloid development (Li et al., 2010; Spooner et al., 2009; Velu et al., 2009). Loss of Gfi1 leads to de-repression of these genes favoring a development towards the monocytic lineage and inhibiting the development of granulocytes. Consequently, Gfi1-/- mice are neutropenic, lack granulocytes and display a strong expansion of atypical Mac-1+, Gr1lo monocytes (Karsunky et al., 2002). The requirement of Gfi1 for the formation of neutrophil granulocytes is corroborated by a report that human patients with neutropenia carry germline mutations in the coding region of Gfi1 affecting the zinc finger regions (Person et al., 2003).

Gfi1 plays a role in the early stages of B-cell differentiation. Evidence for this comes mainly from the study of Gfi1 deficient mice that show reduced numbers of CLPs (an early yet not fully committed B-cell lineage progenitor) and a defective maturation of early B-lineage precursors, which leads to a reduced number of B-220+ cells in bone marrow and spleen (Rathinam et al., 2008). One important factor in the early steps of B-cell development is the cytokine Interleukin 7 (IL-7) and its receptor IL-7R. Gfi1 interferes with IL-7/IL-7R signaling by regulating the activity of Janus kinases (Jak) and subsequently the phosphorylation of STAT5, which is an important downstream signaling molecule in the IL-7R pathway. While the details of this regulatory function remain to be elucidated, Gfi1 seems to be involved in the control of the expression level of the Jak inhibitor SOCS3 (Rathinam and Klein, 2007; Yasukawa et al., 2000).
Besides the IL-7R pathway, Gfi1 also regulated the expression of PU.1, which is another transcription factor with an important role in both myeloid and lymphoid development. PU.1 enables precursors to differentiate into certain lineages and high levels favor myeloid over lymphoid development. Gfi1 regulates the function of PU.1 by two mechanisms: Gfi1 can form a complex with PU.1 and inhibits binding of PU.1 to its target genes. In addition, Gfi1 also binds independently of PU.1 to PU.1 target genes and represses their transcriptional activation (Dahl et al., 2007; Spooner et al., 2009; Wilson et al., 2010). In the absence of Gfi1, PU.1 is thus hyperactive and drives precursors into the myeloid lineage while impeding the formation of lymphoid cells, in particular B-cells. By reducing PU.1 protein quantity (e.g. heterozygosity of PU.1) in Gfi1 deficient mice, B-cell differentiation defects can be overcome (Spooner et al., 2009). Based on these and other findings, interactive regulatory networks have been proposed, in which Gfi1 favors B-cell development whereas PU.1 and Egr1 inhibit B-cell development and favor monocytic differentiation (Spooner et al., 2009).
PU.1 and EGR1/Nab also induce the expression of different Id (Inhibitor of DNA binding) proteins. Gfi1 on the other hand represses Id2 expression. Thus Gfi1-deficiency correlates with increased Id1 and Id2 levels in particular thymocyte subsets (Yücel et al., 2003). Ids mainly function by restricting access of the transcription factor E2A to DNA. E2A, in conjunction with EBF, is required to induce B-cell specific factors such as Pax5 or Rag1/Rag2. Hence, high expression of Id proteins contributes to the Gfi1 deficiency phenotype (Spooner et al., 2009), as they impede up-regulation of these important B-lineage regulators. Consequently knock-down or heterozygosity of Id2 in Gfi1 deficient mice rescues partially the disturbed differentiation of B-cells. To fulfill all these regulatory tasks, Gfi1 itself has to be induced upon initiation of B-cell lineage commitment. Ikaros, another transcription factor important for early B-cell differentiation, acts upstream of Gfi1 and ensures its up-regulation after commitment of the progenitors to the lymphoid lineage (Spooner et al., 2009).
Gfi1 is also required for the maturation and activity of B-cells. Gfi1 restricts an overshooting of antibody production after antigenic stimulation. When challenged with different antigens in-vivo, Gfi1 deficient mice exhibited a higher number of PNA/CD19+ germinal center B-cells in the spleen and accentuated production of antigen specific IgG2a and IgG2b antibodies (Igwe et al., 2008). On the molecular level, increased level of TGF beta might explain this, as TGF beta promotes expression levels of different IgG subtypes. In accordance with disturbed regulation of the immune response, Gfi1 deficient mice are characterized by an increased predisposition to develop autoimmune diseases (Park et al., 2005; Snapper et al., 1993).

T-cell development
Gfi1 deficient mice have a reduced number of thymocytes compared to littermate controls (Karsunky et al., 2002; Yücel et al., 2003; Yücel et al., 2004). This is the result of a disturbed pre T-cell differentiation at different stages. Gfi1 is required for the proper transition from the DN1 to DN2 stage, to control beta selection in DN3 cells and to promote formation of DP cells (Yücel et al., 2003; Yücel et al., 2004). As in the case of B-cell development, one explanation for these deficiencies is a function of Gfi1 in the regulation of IL-7R signaling. One hypothesis would be that unrestricted SOCS3 signaling in the absence of Gfi1 would disturb IL-7 receptor signaling in thymocytes, but this remains to be shown. Also similar to the B-cell fraction, an unbalanced expression of PU.1, Egr and Id proteins may affect the differentiation of the ETPs to the different DN stages (Li et al., 2010; Spooner et al., 2009). Other pathways that are important in pre T-cell development such as those initiated by Notch, Wnt or the pre-TCR itself remain to be analyzed in Gfi1 deficient mice to gain more insight into the full spectrum of Gfi1's regulatory role in this compartment.
Gfi1 is also implicated in the differentiation and activation of the mature peripheral T-cell subpopulations. Generally, Gfi1 is important for the proper function and development of CD4 T-cells (Pargmann et al., 2007). And more specifically, within the CD4 T-cell fraction, Gfi1 plays a major role in Th2 cells. Loss of Gfi1 is associated with decreased number of Th2 cells and increased number of Treg-cells (Ichiyama et al., 2009; Shinnakasu et al., 2008; Zhu et al., 2006).

- Functions of GFI1 outside the hematopoietic system

Outside the hematopoietic system, Gfi1 is required for the integrity and function of inner ear hair cells and in the central nervous system for Purkinje cells. In addition Gfi1 plays a role in the lineage decision process during intestinal cell differentiation (Bjerknes and Cheng, 2010; Hertzano et al., 2004; Shroyer et al., 2005; Tsuda et al., 2005; Wallis et al., 2003). Gfi1 deficient mice show defects in all these cell lineages, but the degeneration of inner ear hair cells is most dramatic since it leads to deafness of the animals (Hertzano et al., 2004; Wallis et al., 2003).


Germinal In patients suffering from neutropenia, two types of mutations have been discovered to occur in the region of the Gfi1 gene coding for its zinc finger domains. This leads to amino acid replacements at two positions; N382S and K403R, respectively. Similar to the neutropenic Gfi1 deficient mice, these patients also display an increased number of aberrant monocytes (Person et al., 2003).
In addition to these mutations, a variant form of Gfi1 (GFI36N) was found that differs from the more common GFI136S form at amino acid position 36, where a serine is replaced by an asparagine. The 36N variant predisposes to the development of acute myeloid leukemia (AML) with an 1.6 times elevated risk for the carriers to develop the disease. On the molecular level, GFI136N features a different nuclear localization than the more common form of GFI (GFI136S). Probably as a result of this aberrant localization, GFI136N is no longer able to interact in-vivo with specific binding partners or co-factors such as AML1/ETO (Khandanpour et al., 2010c).

Implicated in

Entity Lung cancer
Note Gfi1 might also be linked to lung cancer, as abundant Gfi1 expression was reported in a certain subtype of lung cancer (small cell lung cancer). In line with this observation, constitutive over expression of Gfi1 enhances the malignancy of lung cancer cells (Kazanjian et al., 2004).
Entity Prostate cancer
Note A role of Gfi1 in the pathogenesis of prostate cancer has been proposed. It was reported that 25-Dihydroxyvitamin D (1,25D) inhibits growth of prostate cancer cells. The cellular synthesis of 25-Dihydroxyvitamin D (1,25D) depends on the presence of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1). However the expression of this enzyme is repressed in prostate cancer cells. One possible explanation for this repression is that Gfi1, which binds to the promoter of this enzyme, is over expressed and thus represses its expression thereby contributing to prostate cancer development (Dwivedi et al., 2005; Dwivedi et al., 2007).
Entity Human leukemia
Note Gfi1 might be involved in the pathogenesis of chronic myeloid leukemia (CML). CML has a tri-phasic course and upon transformation from the least aggressive stage (chronic phase) to the most aggressive stage (blast crisis) an upregulation of Gfi1 expression was reported (Huang et al., 2010).
Entity Murine leukemia
Note Infection of mice with the non-acute transforming Moloney-type retrovirus (MoMuLV) leads to development of clonal T-cell lymphomas (Mikkers and Berns, 2003). Common proviral insertions that are selected for during tumorigenesis typically include genomic areas close to neighbouring oncogenes. The Gfi1 gene is one of the most frequent common insertion sites in MoMuLV induced tumors, comparable to sites close to the c-Myc and Pim-1 oncogenes (Scheijen et al., 1997; Schmidt et al., 1998; Zörnig et al., 1996). This suggested a causal role of Gfi1 in T-cell tumorigenesis. Constitutive over expression of Gfi1 accelerated the onset of T-cell leukemia in conjunction with the expression of other oncogenes such as Pim1 or L-Myc (Schmidt et al., 1998; Zörnig et al., 1996). These early experiments established the role of Gfi1 as a dominant oncogene in T-cell tumorigenesis.
Entity Autoimmune diseases
Note Loss of Gfi1 induces a number of autoimmune diseases in mice, which can be explained by the loss of function of Gfi1 deficient B- and T-cells. So far, a role for Gfi1 in human autoimmune diseases has yet to be found (Rathinam et al., 2008).


Key players for T-cell regeneration.
Awong G, LaMotte-Mohs R, Zuniga-Pflucker JC.
Curr Opin Hematol. 2010 Jul;17(4):327-32. (REVIEW)
PMID 20571395
Chromosomal localization of a gene, GF1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents.
Bell DW, Taguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Gilks CB, Zweidler-McKay P, Grimes HL, Tsichlis PN, Testa JR.
Cytogenet Cell Genet. 1995;70(3-4):263-7.
PMID 7789186
Cell Lineage metastability in Gfi1-deficient mouse intestinal epithelium.
Bjerknes M, Cheng H.
Dev Biol. 2010 Sep 1;345(1):49-63. Epub 2010 Jun 20.
PMID 20599897
The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction.
Dahl R, Iyer SR, Owens KS, Cuylear DD, Simon MC.
J Biol Chem. 2007 Mar 2;282(9):6473-83. Epub 2006 Dec 31.
PMID 17197705
Positive selection of T cells, an in vitro view.
Dervovic D, Zuniga-Pflucker JC.
Semin Immunol. 2010 Oct;22(5):276-86. (REVIEW)
PMID 20537907
Targets of the transcriptional repressor oncoprotein Gfi-1.
Duan Z, Horwitz M.
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5932-7. Epub 2003 Apr 29.
PMID 12721361
Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
Duan Z, Zarebski A, Montoya-Durango D, Grimes HL, Horwitz M.
Mol Cell Biol. 2005 Dec;25(23):10338-51.
PMID 16287849
Role of oncoprotein growth factor independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): a comparative analysis in human prostate cancer and kidney cells.
Dwivedi PP, Anderson PH, Tilley WD, May BK, Morris HA.
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):742-6. Epub 2007 Jan 5.
PMID 17207994
Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein.
Gilks CB, Bear SE, Grimes HL, Tsichlis PN.
Mol Cell Biol. 1993 Mar;13(3):1759-68.
PMID 8441411
The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal.
Grimes HL, Chan TO, Zweidler-McKay PA, Tong B, Tsichlis PN.
Mol Cell Biol. 1996 Nov;16(11):6263-72.
PMID 8887656
Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfi1 as a target of the Pou4f3 deafness gene.
Hertzano R, Montcouquiol M, Rashi-Elkeles S, Elkon R, Yucel R, Frankel WN, Rechavi G, Moroy T, Friedman TB, Kelley MW, Avraham KB.
Hum Mol Genet. 2004 Sep 15;13(18):2143-53. Epub 2004 Jul 14.
PMID 15254021
Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.
Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, Orkin SH.
Nature. 2004 Oct 21;431(7011):1002-7. Epub 2004 Sep 29.
PMID 15457180
The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro.
Holmes R, Zuniga-Pflucker JC.
Cold Spring Harb Protoc. 2009 Feb;2009(2):pdb.prot5156.
PMID 20147086
Gfi1 integrates progenitor versus granulocytic transcriptional programming.
Horman SR, Velu CS, Chaubey A, Bourdeau T, Zhu J, Paul WE, Gebelein B, Grimes HL.
Blood. 2009 May 28;113(22):5466-75. Epub 2009 Apr 3.
PMID 19346496
The growth factor independence-1 (Gfi1) is overexpressed in chronic myelogenous leukemia.
Huang M, Hu Z, Chang W, Ou D, Zhou J, Zhang Y.
Acta Haematol. 2010;123(1):1-5. Epub 2009 Nov 2.
PMID 19887785
Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity.
Ichiyama K, Hashimoto M, Sekiya T, Nakagawa R, Wakabayashi Y, Sugiyama Y, Komai K, Saba I, Moroy T, Yoshimura A.
Int Immunol. 2009 Jul;21(7):881-9. Epub 2009 Jun 7.
PMID 19505891
The zinc finger protein Gfi1 is implicated in the regulation of IgG2b production and the expression of Igamma2b germline transcripts.
Igwe E, Kosan C, Khandanpour C, Sharif-Askari E, Brune B, Moroy T.
Eur J Immunol. 2008 Nov;38(11):3004-14.
PMID 18991277
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1.
Karsunky H, Zeng H, Schmidt T, Zevnik B, Kluge R, Schmid KW, Duhrsen U, Moroy T.
Nat Genet. 2002 Mar;30(3):295-300. Epub 2002 Jan 28.
PMID 11810106
Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.
Kazanjian A, Wallis D, Au N, Nigam R, Venken KJ, Cagle PT, Dickey BF, Bellen HJ, Gilks CB, Grimes HL.
Cancer Res. 2004 Oct 1;64(19):6874-82.
PMID 15466176
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.
Khandanpour C, Thiede C, Valk PJ, Sharif-Askari E, Nuckel H, Lohmann D, Horsthemke B, Siffert W, Neubauer A, Grzeschik KH, Bloomfield CD, Marcucci G, Maharry K, Slovak ML, van der Reijden BA, Jansen JH, Schackert HK, Afshar K, Schnittger S, Peeters JK, Kroschinsky F, Ehninger G, Lowenberg B, Duhrsen U, Moroy T.
Blood. 2010c Mar 25;115(12):2462-72. Epub 2010 Jan 14.
PMID 20075157
Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development.
Li H, Ji M, Klarmann KD, Keller JR.
Blood. 2010 Aug 19;116(7):1060-9. Epub 2010 May 7.
PMID 20453161
Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signals.
Michie AM, Chan AC, Ciofani M, Carleton M, Lefebvre JM, He Y, Allman DM, Wiest DL, Zuniga-Pflucker JC, Izon DJ.
Int Immunol. 2007 Dec;19(12):1421-30. Epub 2007 Nov 1.
PMID 17981791
Retroviral insertional mutagenesis: tagging cancer pathways.
Mikkers H, Berns A.
Adv Cancer Res. 2003;88:53-99. (REVIEW)
PMID 12665053
The zinc finger transcription factor Growth factor independence 1 (Gfi1).
Moroy T.
Int J Biochem Cell Biol. 2005 Mar;37(3):541-6. (REVIEW)
PMID 15618011
Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function.
Pargmann D, Yucel R, Kosan C, Saba I, Klein-Hitpass L, Schimmer S, Heyd F, Dittmer U, Moroy T.
Eur J Immunol. 2007 Dec;37(12):3551-63.
PMID 18034420
Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching.
Park SR, Seo GY, Choi AJ, Stavnezer J, Kim PH.
Eur J Immunol. 2005 Mar;35(3):946-56.
PMID 15688346
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.
Person RE, Li FQ, Duan Z, Benson KF, Wechsler J, Papadaki HA, Eliopoulos G, Kaufman C, Bertolone SJ, Nakamoto B, Papayannopoulou T, Grimes HL, Horwitz M.
Nat Genet. 2003 Jul;34(3):308-12.
PMID 12778173
Transcription factor Gfi1 restricts B cell-mediated autoimmunity.
Rathinam C, Lassmann H, Mengel M, Klein C.
J Immunol. 2008 Nov 1;181(9):6222-9.
PMID 18941212
Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1.
Saleque S, Kim J, Rooke HM, Orkin SH.
Mol Cell. 2007 Aug 17;27(4):562-72.
PMID 17707228
Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.
Scheijen B, Jonkers J, Acton D, Berns A.
J Virol. 1997 Jan;71(1):9-16.
PMID 8985317
Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP, Moroy T.
Oncogene. 1998 Nov 19;17(20):2661-7.
PMID 9840930
Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation.
Shinnakasu R, Yamashita M, Kuwahara M, Hosokawa H, Hasegawa A, Motohashi S, Nakayama T.
J Biol Chem. 2008 Oct 17;283(42):28216-25. Epub 2008 Aug 13.
PMID 18701459
Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation.
Shroyer NF, Wallis D, Venken KJ, Bellen HJ, Zoghbi HY.
Genes Dev. 2005 Oct 15;19(20):2412-7.
PMID 16230531
Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
Snapper CM, Waegell W, Beernink H, Dasch JR.
J Immunol. 1993 Nov 1;151(9):4625-36.
PMID 8409423
A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates.
Spooner CJ, Cheng JX, Pujadas E, Laslo P, Singh H.
Immunity. 2009 Oct 16;31(4):576-86. Epub 2009 Oct 8.
PMID 19818654
The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.
Tsuda H, Jafar-Nejad H, Patel AJ, Sun Y, Chen HK, Rose MF, Venken KJ, Botas J, Orr HT, Bellen HJ, Zoghbi HY.
Cell. 2005 Aug 26;122(4):633-44.
PMID 16122429
Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1.
Vassen L, Okayama T, Moroy T.
Blood. 2007 Mar 15;109(6):2356-64. Epub 2006 Nov 9.
PMID 17095621
Gfi1 regulates miR-21 and miR-196b to control myelopoiesis.
Velu CS, Baktula AM, Grimes HL.
Blood. 2009 May 7;113(19):4720-8. Epub 2009 Mar 10.
PMID 19278956
The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival.
Wallis D, Hamblen M, Zhou Y, Venken KJ, Schumacher A, Grimes HL, Zoghbi HY, Orkin SH, Bellen HJ.
Development. 2003 Jan;130(1):221-32.
PMID 12441305
Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.
Wang L, Xiong Y, Bosselut R.
Semin Immunol. 2010 Oct;22(5):294-302. (REVIEW)
PMID 20537906
Gfi1 expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells.
Wilson NK, Timms RT, Kinston SJ, Cheng YH, Oram SH, Landry JR, Mullender J, Ottersbach K, Gottgens B.
Mol Cell Biol. 2010 Aug;30(15):3853-63. Epub 2010 Jun 1.
PMID 20516218
Negative regulation of cytokine signaling pathways.
Yasukawa H, Sasaki A, Yoshimura A.
Annu Rev Immunol. 2000;18:143-64. (REVIEW)
PMID 10837055
The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus.
Yucel R, Karsunky H, Klein-Hitpass L, Moroy T.
J Exp Med. 2003 Apr 7;197(7):831-44.
PMID 12682108
Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development.
Yucel R, Kosan C, Heyd F, Moroy T.
J Biol Chem. 2004 Sep 24;279(39):40906-17. Epub 2004 Jul 13.
PMID 15252036
Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.
Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T.
EMBO J. 2004 Oct 13;23(20):4116-25. Epub 2004 Sep 23.
PMID 15385956
Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion.
Zhu J, Jankovic D, Grinberg A, Guo L, Paul WE.
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18214-9. Epub 2006 Nov 20.
PMID 17116877
Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T.
Oncogene. 1996 Apr 18;12(8):1789-801.
PMID 8622900
The original intrathymic progenitor from which T cells originate.
Zuniga-Pflucker JC.
J Immunol. 2009 Jul 1;183(1):3-4. (REVIEW)
PMID 19542424
Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor.
Zweidler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN.
Mol Cell Biol. 1996 Aug;16(8):4024-34.
PMID 8754800


This paper should be referenced as such :
Möröy, T ; Khandanpour, C
GFI1 (growth factor independent 1 transcription repressor)
Atlas Genet Cytogenet Oncol Haematol. 2011;15(10):821-827.
Free journal version : [ pdf ]   [ DOI ]

Other Leukemias implicated (Data extracted from papers in the Atlas) [ 1 ]
  inv(16)(p13q24) CBFA2T3/GLIS2

External links

HGNC (Hugo)GFI1   4237
LRG (Locus Reference Genomic)LRG_63
Entrez_Gene (NCBI)GFI1    growth factor independent 1 transcriptional repressor
AliasesGFI-1; GFI1A; SCN2; ZNF163
GeneCards (Weizmann)GFI1
Ensembl hg19 (Hinxton)ENSG00000162676 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000162676 [Gene_View]  ENSG00000162676 [Sequence]  chr1:92473043-92486925 [Contig_View]  GFI1 [Vega]
ICGC DataPortalENSG00000162676
TCGA cBioPortalGFI1
AceView (NCBI)GFI1
Genatlas (Paris)GFI1
SOURCE (Princeton)GFI1
Genetics Home Reference (NIH)GFI1
Genomic and cartography
GoldenPath hg38 (UCSC)GFI1  -     chr1:92473043-92486925 -  1p22.1   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)GFI1  -     1p22.1   [Description]    (hg19-Feb_2009)
GoldenPathGFI1 - 1p22.1 [CytoView hg19]  GFI1 - 1p22.1 [CytoView hg38]
genome Data Viewer NCBIGFI1 [Mapview hg19]  
OMIM600871   607847   613107   
Gene and transcription
Genbank (Entrez)AB209606 AK123009 AK313876 AW086150 BC032751
RefSeq transcript (Entrez)NM_001127215 NM_001127216 NM_005263
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)GFI1
Alternative Splicing GalleryENSG00000162676
Gene ExpressionGFI1 [ NCBI-GEO ]   GFI1 [ EBI - ARRAY_EXPRESS ]   GFI1 [ SEEK ]   GFI1 [ MEM ]
Gene Expression Viewer (FireBrowse)GFI1 [ Firebrowse - Broad ]
GenevisibleExpression of GFI1 in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)2672
GTEX Portal (Tissue expression)GFI1
Human Protein AtlasENSG00000162676-GFI1 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ99684   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ99684  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ99684
Splice isoforms : SwissVarQ99684
Domaine pattern : Prosite (Expaxy)ZINC_FINGER_C2H2_1 (PS00028)    ZINC_FINGER_C2H2_2 (PS50157)   
Domains : Interpro (EBI)GFI1/1B    Znf_C2H2_sf    Znf_C2H2_type   
Domain families : Pfam (Sanger)zf-C2H2 (PF00096)   
Domain families : Pfam (NCBI)pfam00096   
Domain families : Smart (EMBL)ZnF_C2H2 (SM00355)  
Conserved Domain (NCBI)GFI1
Blocks (Seattle)GFI1
Human Protein Atlas [tissue]ENSG00000162676-GFI1 [tissue]
Peptide AtlasQ99684
Protein Interaction databases
IntAct (EBI)Q99684
Ontologies - Pathways
Ontology : AmiGO"regulation of transcription involved in G1/S transition of mitotic cell cycle  negative regulation of transcription by RNA polymerase II  transcription regulatory region sequence-specific DNA binding  transcription regulatory region sequence-specific DNA binding  DNA-binding transcription repressor activity, RNA polymerase II-specific  DNA-binding transcription factor activity  protein binding  nucleus  nucleoplasm  negative regulation of calcidiol 1-monooxygenase activity  negative regulation of vitamin D biosynthetic process  negative regulation of neuron projection development  viral process  nuclear matrix  nuclear body  transcriptional repressor complex  hemopoiesis  negative regulation of NF-kappaB transcription factor activity  regulation of toll-like receptor signaling pathway  negative regulation of transcription, DNA-templated  positive regulation of transcription by RNA polymerase II  metal ion binding  regulation of histone H3-K4 methylation  positive regulation of interleukin-6-mediated signaling pathway  cellular response to lipopolysaccharide"  
Ontology : EGO-EBI"regulation of transcription involved in G1/S transition of mitotic cell cycle  negative regulation of transcription by RNA polymerase II  transcription regulatory region sequence-specific DNA binding  transcription regulatory region sequence-specific DNA binding  DNA-binding transcription repressor activity, RNA polymerase II-specific  DNA-binding transcription factor activity  protein binding  nucleus  nucleoplasm  negative regulation of calcidiol 1-monooxygenase activity  negative regulation of vitamin D biosynthetic process  negative regulation of neuron projection development  viral process  nuclear matrix  nuclear body  transcriptional repressor complex  hemopoiesis  negative regulation of NF-kappaB transcription factor activity  regulation of toll-like receptor signaling pathway  negative regulation of transcription, DNA-templated  positive regulation of transcription by RNA polymerase II  metal ion binding  regulation of histone H3-K4 methylation  positive regulation of interleukin-6-mediated signaling pathway  cellular response to lipopolysaccharide"  
NDEx NetworkGFI1
Atlas of Cancer Signalling NetworkGFI1
Wikipedia pathwaysGFI1
Orthology - Evolution
GeneTree (enSembl)ENSG00000162676
Phylogenetic Trees/Animal Genes : TreeFamGFI1
Homologs : HomoloGeneGFI1
Homology/Alignments : Family Browser (UCSC)GFI1
Gene fusions - Rearrangements
Fusion : Fusion_HubGFI1B--GFI1   
Fusion : QuiverGFI1
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerGFI1 [hg38]
Exome Variant ServerGFI1
GNOMAD BrowserENSG00000162676
Varsome BrowserGFI1
Genomic Variants (DGV)GFI1 [DGVbeta]
DECIPHERGFI1 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisGFI1 
ICGC Data PortalGFI1 
TCGA Data PortalGFI1 
Broad Tumor PortalGFI1
OASIS PortalGFI1 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICGFI1  [overview]  [genome browser]  [tissue]  [distribution]  
Somatic Mutations in Cancer : COSMIC3DGFI1
Mutations and Diseases : HGMDGFI1
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
LOVD (Leiden Open Variation Database)**PUBLIC** CCHMC Molecular Genetics Laboratory Mutation Database
BioMutasearch GFI1
DgiDB (Drug Gene Interaction Database)GFI1
DoCM (Curated mutations)GFI1 (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)GFI1 (select a term)
NCG6 (London) select GFI1
Cancer3DGFI1(select the gene name)
Impact of mutations[PolyPhen2] [Provean] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
OMIM600871    607847    613107   
Genetic Testing Registry GFI1
NextProtQ99684 [Medical]
Target ValidationGFI1
Huge Navigator GFI1 [HugePedia]
Clinical trials, drugs, therapy
Protein Interactions : CTD
Pharm GKB GenePA24344
Clinical trialGFI1
canSAR (ICR)GFI1 (select the gene name)
DataMed IndexGFI1
PubMed76 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Feb 19 17:51:29 CET 2021

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us